Evaluating mRNA Expression Levels of the TLR4/IRF5 Signaling Axis During Hepatic Ischemia-Reperfusion Injuries

Abstract

Objectives: Hepatic ischemia and reperfusion during liver transplant surgery result in hepatocellular damage. Toll-like receptors, especially TLR4, have a fundamental basic role in the inflammatory phase of ischemia-reperfusion injuries. The effect of the TRIFdependent signaling pathway downstream of TLR4 in hepatic ischemia-reperfusion injury has been well established. However, the role of TLR4-MyD88-dependent signal transduction in hepatic ischemiareperfusion injury has not yet been clarified. The interferon regulatory factor 5 was introduced as the main regulator of the TLR4-MyD88 signaling pathway for activating proinflammatory cytokines. The present study was carried out to investigate the functional impact of the TLR4/IRF5 signaling axis in hepatic ischemia-reperfusion injury. Materials and Methods: mRNA expression levels of TLR4, IRF5, tumor necrosis factor α, interleukin 1β, and interleukin 6 were measured using real-time polymerase chain reaction after short (3 h) and long (168 h) reperfusion periods in a hepatic mouse model of ischemia-reperfusion injury in the presence and absence of N-acetylcysteine. Liver damage was evaluated by plasma levels of alanine aminotransferase and histopathology. Results: Our results show that mRNA levels of TLR4/IRF5 and its downstream cytokines were significantly elevated 3 hours after reperfusion and had drastically fallen to baseline levels 168 hours after reperfusion. Plasma levels of alanine aminotransferase showed the same pattern. Histopathologic study of the samples revealed significant hepatic cell infiltration and necrosis 168 hours after reperfusion. Pretreatment with N-acetylcysteine significantly decreased the mRNA levels of TLR4/IRF5 and its downstream cytokines 3 hours after reperfusion and subsequently improved the previously mentioned hepatic damages 168 hours after reperfusion. Conclusions: This study suggests a possible role for the TLR4/IRF5 signaling pathway in hepatic ischemiareperfusion injury. Furthermore, it reveals that Nacetylcysteine may suppress this inflammatory axis and consequently improve hepatic injuries.

Corilagin relieves atherosclerosis via the toll-like receptor 4 signaling pathway in vascular smooth muscle cells

“… 49 IRF5 expression is altered in tandem with TLR4 expression following N-acetylcysteine treatment. 50 Our study demonstrated that both the downregulation and upregulation of TLR4 expression in MOVAS cells resulted in similar variations in the expression of TIRAP, MyD88, TRAF6, p38, NEMO, and IRF5. This observation suggests the existence of a potential positive feedback mechanism between TLR4 and its downstream molecules.…”

Expression of Apoptosis-Related Genes in Cultured Ovarian Tissue of Mouse in Presence of Coenzyme Q10

“…Relative quantification analysis was performed using the 2 −ΔΔCT method. The primers of the Bcl-2 , Bax , Bad and Caspase -3 genes were designed by AlleleID software (Primier Biosoft, USA) and the elongation factor 1 ( Ef1 ) gene was used as a housekeeping gene ( 24 ) ( Table 1 ).…”

The Role of Interferon Regulatory Factors in Liver Diseases

“…IRF1 and IRF5 expression were found to be significantly increased in the liver following exposure to IRI [75,81]. IRF1 had been shown to have a detrimental impact on hepatic IRI by regulating the expression of various inflammatory mediators.…”